1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015

Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiovascular Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiovascular Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiovascular Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiovascular Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Cardiovascular Surgery Devices Overview 17
3 Products under Development 19
3.1 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 19
3.2 Cardiovascular Surgery Devices - Pipeline Products by Segment 20
3.3 Cardiovascular Surgery Devices - Pipeline Products by Territory 21
3.4 Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 23
3.5 Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 24
3.6 Cardiovascular Surgery Devices - Ongoing Clinical Trials 25
4 Cardiovascular Surgery Devices - Pipeline Products under Development by Companies 26
4.1 Cardiovascular Surgery Devices Companies - Pipeline Products by Stage of Development 26
4.2 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 30
5 Cardiovascular Surgery Devices Companies and Product Overview 34
5.1 3S BioMedical, Inc. Company Overview 34
5.1.1 3S BioMedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
5.2 AblaCor Medical Corporation Company Overview 35
5.2.1 AblaCor Medical Corporation Pipeline Products and Ongoing Clinical Trials Overview 35
5.3 Advanced Catheter Therapies, Inc. Company Overview 36
5.3.1 Advanced Catheter Therapies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
5.4 AdvanSource Biomaterials Corporation Company Overview 38
5.4.1 AdvanSource Biomaterials Corporation Pipeline Products and Ongoing Clinical Trials Overview 38
5.5 AFreeze GmbH Company Overview 42
5.5.1 AFreeze GmbH Pipeline Products and Ongoing Clinical Trials Overview 42
5.6 Anethon (Inactive) Company Overview 47
5.6.1 Anethon (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 47
5.7 AngioDynamics, Inc. Company Overview 48
5.7.1 AngioDynamics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
5.8 Apaxis Medical, Inc. Company Overview 51
5.8.1 Apaxis Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 51
5.9 APK Advanced Medical Technologies, Inc. Company Overview 55
5.9.1 APK Advanced Medical Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
5.10 Arterion AB Company Overview 56
5.10.1 Arterion AB Pipeline Products and Ongoing Clinical Trials Overview 56
5.11 AtriCure, Inc. Company Overview 57
5.11.1 AtriCure, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
5.12 Axcelon Biopolymers Corp. Company Overview 61
5.12.1 Axcelon Biopolymers Corp. Pipeline Products and Ongoing Clinical Trials Overview 61
5.13 Beth Israel Deaconess Medical Center, Inc. Company Overview 62
5.13.1 Beth Israel Deaconess Medical Center, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
5.14 Bioretec Ltd. Company Overview 64
5.14.1 Bioretec Ltd. Pipeline Products and Ongoing Clinical Trials Overview 64
5.15 Boston University Company Overview 65
5.15.1 Boston University Pipeline Products and Ongoing Clinical Trials Overview 65
5.16 CardioPolymers, Inc. Company Overview 67
5.16.1 CardioPolymers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 67
5.17 CardioPrecision Ltd Company Overview 68
5.17.1 CardioPrecision Ltd Pipeline Products and Ongoing Clinical Trials Overview 68
5.18 CardioScout, LLC Company Overview 69
5.18.1 CardioScout, LLC Pipeline Products and Ongoing Clinical Trials Overview 69
5.19 CellProthera Company Overview 70
5.19.1 CellProthera Pipeline Products and Ongoing Clinical Trials Overview 70
5.20 Children's Hospital Boston Company Overview 72
5.20.1 Children's Hospital Boston Pipeline Products and Ongoing Clinical Trials Overview 72
5.21 Circulatory Technology Inc. Company Overview 74
5.21.1 Circulatory Technology Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
5.22 Cleveland Clinic Hospital Company Overview 75
5.22.1 Cleveland Clinic Hospital Pipeline Products and Ongoing Clinical Trials Overview 75
5.23 Corazon Technologies, Inc. Company Overview 77
5.23.1 Corazon Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 77
5.24 CorMatrix Cardiovascular, Inc. Company Overview 78
5.24.1 CorMatrix Cardiovascular, Inc. Pipeline Products and Ongoing Clinical Trials Overview 78
5.25 Coromedic Ltd. Company Overview 81
5.25.1 Coromedic Ltd. Pipeline Products and Ongoing Clinical Trials Overview 81
5.26 CPSI Biotech Company Overview 83
5.26.1 CPSI Biotech Pipeline Products and Ongoing Clinical Trials Overview 83
5.27 Cytograft Tissue Engineering, Inc. Company Overview 84
5.27.1 Cytograft Tissue Engineering, Inc. Pipeline Products and Ongoing Clinical Trials Overview 84
5.28 Design Mentor, Inc. Company Overview 88
5.28.1 Design Mentor, Inc. Pipeline Products and Ongoing Clinical Trials Overview 88
5.29 Edwards Lifesciences Corporation Company Overview 89
5.29.1 Edwards Lifesciences Corporation Pipeline Products and Ongoing Clinical Trials Overview 89
5.30 Elana bv Company Overview 91
5.30.1 Elana bv Pipeline Products and Ongoing Clinical Trials Overview 91
5.31 Emory University Company Overview 92
5.31.1 Emory University Pipeline Products and Ongoing Clinical Trials Overview 92
5.32 Endogene Ltd Company Overview 94
5.32.1 Endogene Ltd Pipeline Products and Ongoing Clinical Trials Overview 94
5.33 EpiEP, Inc. Company Overview 97
5.33.1 EpiEP, Inc. Pipeline Products and Ongoing Clinical Trials Overview 97
5.34 European Medical Contract Manufacturing B.V. Company Overview 98
5.34.1 European Medical Contract Manufacturing B.V. Pipeline Products and Ongoing Clinical Trials Overview 98
5.35 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Company Overview 99
5.35.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Pipeline Products and Ongoing Clinical Trials Overview 99
5.36 Graft-Loc Inc. Company Overview 100
5.36.1 Graft-Loc Inc. Pipeline Products and Ongoing Clinical Trials Overview 100
5.37 H. Lee Moffitt Cancer Center and Research Institute, Inc. Company Overview 101
5.37.1 H. Lee Moffitt Cancer Center and Research Institute, Inc. Pipeline Products and Ongoing Clinical Trials Overview 101
5.38 Harpoon Medical, Inc. Company Overview 103
5.38.1 Harpoon Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 103
5.39 HeartLander Surgical, Inc. Company Overview 106
5.39.1 HeartLander Surgical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 106
5.40 Helical Solutions, Inc. Company Overview 107
5.40.1 Helical Solutions, Inc. Pipeline Products and Ongoing Clinical Trials Overview 107
5.41 Hocor Cardiovascular Technologies, LLC Company Overview 108
5.41.1 Hocor Cardiovascular Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 108
5.42 iiTech BV Company Overview 109
5.42.1 iiTech BV Pipeline Products and Ongoing Clinical Trials Overview 109
5.43 Kardium Inc. Company Overview 112
5.43.1 Kardium Inc. Pipeline Products and Ongoing Clinical Trials Overview 112
5.44 Kips Bay Medical, Inc. Company Overview 116
5.44.1 Kips Bay Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 116
5.45 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 118
5.45.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 118
5.46 LivaNova PLC Company Overview 119
5.46.1 LivaNova PLC Pipeline Products and Ongoing Clinical Trials Overview 119
5.47 LuxCath, LLC Company Overview 126
5.47.1 LuxCath, LLC Pipeline Products and Ongoing Clinical Trials Overview 126
5.48 Magenta Medical Inc Company Overview 127
5.48.1 Magenta Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 127
5.49 Mayo Clinic. Company Overview 128
5.49.1 Mayo Clinic. Pipeline Products and Ongoing Clinical Trials Overview 128
5.50 MedArray Inc. Company Overview 129
5.50.1 MedArray Inc. Pipeline Products and Ongoing Clinical Trials Overview 129
5.51 Medrobotics Corporation Company Overview 132
5.51.1 Medrobotics Corporation Pipeline Products and Ongoing Clinical Trials Overview 132
5.52 Medtronic plc Company Overview 134
5.52.1 Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 134
5.53 Michigan Critical Care Consultants, Inc. Company Overview 136
5.53.1 Michigan Critical Care Consultants, Inc. Pipeline Products and Ongoing Clinical Trials Overview 136
5.54 MicroPort Scientific Corporation Company Overview 137
5.54.1 MicroPort Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 137
5.55 Neograft Technologies, Inc. Company Overview 139
5.55.1 Neograft Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 139
5.56 Nipro Corporation Company Overview 142
5.56.1 Nipro Corporation Pipeline Products and Ongoing Clinical Trials Overview 142
5.57 Northwestern University Company Overview 145
5.57.1 Northwestern University Pipeline Products and Ongoing Clinical Trials Overview 145
5.58 NovelMed Therapeutics, Inc. Company Overview 148
5.58.1 NovelMed Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 148
5.59 Novogate Medical Ltd. Company Overview 149
5.59.1 Novogate Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 149
5.60 NuPulse Inc Company Overview 150
5.60.1 NuPulse Inc Pipeline Products and Ongoing Clinical Trials Overview 150
5.61 NuVascular Technologies Inc Company Overview 151
5.61.1 NuVascular Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 151
5.62 Prekubator TTO Company Overview 152
5.62.1 Prekubator TTO Pipeline Products and Ongoing Clinical Trials Overview 152
5.63 Protego Medical Pty Ltd Company Overview 153
5.63.1 Protego Medical Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 153
5.64 Rafael Medical Technologies, Inc. Company Overview 154
5.64.1 Rafael Medical Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 154
5.65 Replication Medical, Inc. Company Overview 155
5.65.1 Replication Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 155
5.66 Revivicor, Inc. Company Overview 157
5.66.1 Revivicor, Inc. Pipeline Products and Ongoing Clinical Trials Overview 157
5.67 SeamVad Ltd. Company Overview 158
5.67.1 SeamVad Ltd. Pipeline Products and Ongoing Clinical Trials Overview 158
5.68 SentreHEART, Inc. Company Overview 160
5.68.1 SentreHEART, Inc. Pipeline Products and Ongoing Clinical Trials Overview 160
5.69 Sorin S.p.A. (Inactive) Company Overview 163
5.69.1 Sorin S.p.A. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 163
5.70 Southern Research Institute Company Overview 166
5.70.1 Southern Research Institute Pipeline Products and Ongoing Clinical Trials Overview 166
5.71 Sree Chitra Tirunal Institute for Medical Sciences and Technology Company Overview 167
5.71.1 Sree Chitra Tirunal Institute for Medical Sciences and Technology Pipeline Products and Ongoing Clinical Trials Overview 167
5.72 St. Jude Medical, Inc. Company Overview 171
5.72.1 St. Jude Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 171
5.73 Stanford University Company Overview 173
5.73.1 Stanford University Pipeline Products and Ongoing Clinical Trials Overview 173
5.74 Synovis Life Technologies, Inc. Company Overview 175
5.74.1 Synovis Life Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 175
5.75 Tengion, Inc. (Inactive) Company Overview 176
5.75.1 Tengion, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 176
5.76 The Johns Hopkins University Company Overview 178
5.76.1 The Johns Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 178
5.77 The Spectranetics Corporation Company Overview 180
5.77.1 The Spectranetics Corporation Pipeline Products and Ongoing Clinical Trials Overview 180
5.78 The University of Utah Company Overview 182
5.78.1 The University of Utah Pipeline Products and Ongoing Clinical Trials Overview 182
5.79 Theracardia Company Overview 184
5.79.1 Theracardia Pipeline Products and Ongoing Clinical Trials Overview 184
5.80 Thermedical, Inc. Company Overview 185
5.80.1 Thermedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 185
5.81 Tissue Regeneration Technologies, LLC Company Overview 187
5.81.1 Tissue Regeneration Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 187
5.82 Trivitron Healthcare Pvt Ltd. Company Overview 189
5.82.1 Trivitron Healthcare Pvt Ltd. Pipeline Products and Ongoing Clinical Trials Overview 189
5.83 Tufts Medical Center Company Overview 190
5.83.1 Tufts Medical Center Pipeline Products and Ongoing Clinical Trials Overview 190
5.84 Universite de Montreal Company Overview 191
5.84.1 Universite de Montreal Pipeline Products and Ongoing Clinical Trials Overview 191
5.85 University College London Company Overview 193
5.85.1 University College London Pipeline Products and Ongoing Clinical Trials Overview 193
5.86 University of Arizona Company Overview 194
5.86.1 University of Arizona Pipeline Products and Ongoing Clinical Trials Overview 194
5.87 University of California, Los Angeles Company Overview 196
5.87.1 University of California, Los Angeles Pipeline Products and Ongoing Clinical Trials Overview 196
5.88 University of Nebraska Company Overview 199
5.88.1 University of Nebraska Pipeline Products and Ongoing Clinical Trials Overview 199
5.89 University of Pittsburgh Company Overview 200
5.89.1 University of Pittsburgh Pipeline Products and Ongoing Clinical Trials Overview 200
5.90 University of Strathclyde Company Overview 202
5.90.1 University of Strathclyde Pipeline Products and Ongoing Clinical Trials Overview 202
5.91 Vanderbilt University Company Overview 203
5.91.1 Vanderbilt University Pipeline Products and Ongoing Clinical Trials Overview 203
5.92 Veniti, Inc. Company Overview 205
5.92.1 Veniti, Inc. Pipeline Products and Ongoing Clinical Trials Overview 205
5.93 Ventrica, Inc. Company Overview 206
5.93.1 Ventrica, Inc. Pipeline Products and Ongoing Clinical Trials Overview 206
5.94 VytronUS, Inc. Company Overview 207
5.94.1 VytronUS, Inc. Pipeline Products and Ongoing Clinical Trials Overview 207
5.95 W-Z BIOTECH, LLC Company Overview 208
5.95.1 W-Z BIOTECH, LLC Pipeline Products and Ongoing Clinical Trials Overview 208
6 Cardiovascular Surgery Devices- Recent Developments 210
7 Appendix 339
7.1 Methodology 339
7.2 About GlobalData 341
7.3 Contact Us 342
7.4 Disclaimer 342

1.1 List of Tables
Table 1: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 19
Table 2: Cardiovascular Surgery Devices - Pipeline Products by Segment 20
Table 3: Cardiovascular Surgery Devices - Pipeline Products by Territory 22
Table 4: Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 23
Table 5: Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 24
Table 6: Cardiovascular Surgery Devices - Ongoing Clinical Trials 25
Table 7: Cardiovascular Surgery Devices Companies - Pipeline Products by Stage of Development 26
Table 8: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 30
Table 9: 3S BioMedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
Table 10: Resorpor Vascular Patch - Product Status 34
Table 11: Resorpor Vascular Patch - Product Description 34
Table 12: AblaCor Medical Corporation Pipeline Products and Ongoing Clinical Trials Overview 35
Table 13: CircumBlator - Product Status 35
Table 14: CircumBlator - Product Description 35
Table 15: Advanced Catheter Therapies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
Table 16: Atherectomy Device - Product Status 36
Table 17: Atherectomy Device - Product Description 36
Table 18: Thrombectomy Device - Product Status 37
Table 19: Thrombectomy Device - Product Description 37
Table 20: AdvanSource Biomaterials Corporation Pipeline Products and Ongoing Clinical Trials Overview 38
Table 21: CardioPass - Product Status 39
Table 22: CardioPass - Product Description 39
Table 23: AdvanSource Biomaterials Corporation - Ongoing Clinical Trials Overview 40
Table 24: CardioPass - CardioPass - European Clinical Trial 41
Table 25: AFreeze GmbH Pipeline Products and Ongoing Clinical Trials Overview 42
Table 26: CoolLoop - Product Status 43
Table 27: CoolLoop - Product Description 43
Table 28: Tip-Catheter - Product Status 44
Table 29: Tip-Catheter - Product Description 44
Table 30: AFreeze GmbH - Ongoing Clinical Trials Overview 45
Table 31: CoolLoop - CoolLoop Paroxysmal Atrial Fibrillation 46
Table 32: Anethon (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 47
Table 33: Cardiovascular Patch - Product Status 47
Table 34: Cardiovascular Patch - Product Description 47
Table 35: AngioDynamics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
Table 36: Next Gen AngioVac Catheter - Product Status 49
Table 37: Next Gen AngioVac Catheter - Product Description 49
Table 38: Non-Thermal Vein Ablation Device - Product Status 50
Table 39: Non-Thermal Vein Ablation Device - Product Description 50
Table 40: Apaxis Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 41: Anastomotic Suturing Connector - Product Status 51
Table 42: Anastomotic Suturing Connector - Product Description 51
Table 43: ApiCor - Product Status 52
Table 44: ApiCor - Product Description 52
Table 45: EasyApex CV - Product Status 53
Table 46: EasyApex CV - Product Description 53
Table 47: Endo LV - Product Status 54
Table 48: Endo LV - Product Description 54
Table 49: APK Advanced Medical Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
Table 50: Apical Access System - Product Status 55
Table 51: Apical Access System - Product Description 55
Table 52: Arterion AB Pipeline Products and Ongoing Clinical Trials Overview 56
Table 53: Arterion Artificial Blood Vessel - Product Status 56
Table 54: Arterion Artificial Blood Vessel - Product Description 56
Table 55: AtriCure, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
Table 56: AtriClip - Stroke Label - Product Status 58
Table 57: AtriClip - Stroke Label - Product Description 58
Table 58: COBRA Fusion 50 - Atrial Fibrillation - Product Status 59
Table 59: COBRA Fusion 50 - Atrial Fibrillation - Product Description 59
Table 60: CryoFORM Cryoablation Probe - Product Status 60
Table 61: CryoFORM Cryoablation Probe - Product Description 60
Table 62: Axcelon Biopolymers Corp. Pipeline Products and Ongoing Clinical Trials Overview 61
Table 63: MC - PVA Based Vascular Graft - Product Status 61
Table 64: MC - PVA Based Vascular Graft - Product Description 61
Table 65: Beth Israel Deaconess Medical Center, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
Table 66: Pericardial Reinforcement Device - Product Status 62
Table 67: Pericardial Reinforcement Device - Product Description 62
Table 68: Tissue Transplant And Regeneration Device - Product Status 63
Table 69: Tissue Transplant And Regeneration Device - Product Description 63
Table 70: Bioretec Ltd. Pipeline Products and Ongoing Clinical Trials Overview 64
Table 71: Bioabsorbable Sternotomy Fixation Device - Product Status 64
Table 72: Bioabsorbable Sternotomy Fixation Device - Product Description 64
Table 73: Boston University Pipeline Products and Ongoing Clinical Trials Overview 65
Table 74: Sternal Approximation Device - Product Status 65
Table 75: Sternal Approximation Device - Product Description 65
Table 76: Tissue Engineered Blood Vessel - Product Status 66
Table 77: Tissue Engineered Blood Vessel - Product Description 66
Table 78: CardioPolymers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 79: Plexisyl-AF - Product Status 67
Table 80: Plexisyl-AF - Product Description 67
Table 81: CardioPrecision Ltd Pipeline Products and Ongoing Clinical Trials Overview 68
Table 82: CardioPrecision Device - Product Status 68
Table 83: CardioPrecision Device - Product Description 68
Table 84: CardioScout, LLC Pipeline Products and Ongoing Clinical Trials Overview 69
Table 85: Minimally Invasive Surgical Device - Product Status 69
Table 86: Minimally Invasive Surgical Device - Product Description 69
Table 87: CellProthera Pipeline Products and Ongoing Clinical Trials Overview 70
Table 88: CellProthera Automated Device - Product Status 71
Table 89: CellProthera Automated Device - Product Description 71
Table 90: Children's Hospital Boston Pipeline Products and Ongoing Clinical Trials Overview 72
Table 91: Cardioport - Product Status 72
Table 92: Cardioport - Product Description 72
Table 93: Millimeter-Scale Device - Product Status 73
Table 94: Millimeter-Scale Device - Product Description 73
Table 95: Circulatory Technology Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
Table 96: Heart Lung Machine - Product Status 74
Table 97: Heart Lung Machine - Product Description 74
Table 98: Cleveland Clinic Hospital Pipeline Products and Ongoing Clinical Trials Overview 75
Table 99: Flexible Fiberoptic Cardioscope - Product Status 75
Table 100: Flexible Fiberoptic Cardioscope - Product Description 75
Table 101: Hyperinsulinemic- Normoglycemic Clamp - Product Status 76
Table 102: Hyperinsulinemic- Normoglycemic Clamp - Product Description 76
Table 103: Corazon Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 77
Table 104: Beating Heart Aortic Valve Repair Demineralization System - Product Status 77
Table 105: Beating Heart Aortic Valve Repair Demineralization System - Product Description 77
Table 106: CorMatrix Cardiovascular, Inc. Pipeline Products and Ongoing Clinical Trials Overview 78
Table 107: CorMatrix ECM-Postoperative Atrial Fibrillation - Product Status 79
Table 108: CorMatrix ECM-Postoperative Atrial Fibrillation - Product Description 79
Table 109: Injectable CorMatrix ECM - Product Status 80
Table 110: Injectable CorMatrix ECM - Product Description 80
Table 111: Coromedic Ltd. Pipeline Products and Ongoing Clinical Trials Overview 81
Table 112: Distal Anastomosis Device - Product Status 81
Table 113: Distal Anastomosis Device - Product Description 81
Table 114: Proximal Anastomosis Device - Product Status 82
Table 115: Proximal Anastomosis Device - Product Description 82
Table 116: CPSI Biotech Pipeline Products and Ongoing Clinical Trials Overview 83
Table 117: ICEolate Platform - Product Status 83
Table 118: ICEolate Platform - Product Description 83
Table 119: Cytograft Tissue Engineering, Inc. Pipeline Products and Ongoing Clinical Trials Overview 84
Table 120: Cytograft Device - Percutaneous Bypass - Product Status 85
Table 121: Cytograft Device - Percutaneous Bypass - Product Description 85
Table 122: LifeLine TEBV - CABG - Product Status 86
Table 123: LifeLine TEBV - CABG - Product Description 86

1.2 List of Figures
Figure 1: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 19
Figure 2: Cardiovascular Surgery Devices - Pipeline Products by Segment 20
Figure 3: Cardiovascular Surgery Devices - Pipeline Products by Territory 21
Figure 4: Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 23
Figure 5: Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 24
Figure 6: Cardiovascular Surgery Devices - Ongoing Clinical Trials 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.